Neuroendocrine Tumors (NET) Images
Study finds genetic link for rare intestinal cancer
National Institutes of Health recently released information revealing that up to 35% of small intestinal carcinoid is genetic. Therefore, people with a family history colon cancer should be routinely screened for this disease.
These types of Neuroendocrine Carcinoma or tumors usually grow slowly and without any symptoms. In many cases it is too late to save the nation once they are diagnosed.
The study was conducted at the NIH clinical Center. The researchers screened a total of 181 candidates from 33 different families. Each family had at least two cases of this cancer.
The genetic genome analysis showed target DNA regions which were shared by each of the family members. Genome sequencing narrow the result down inherited family risk factor for the disease.
This research clearly shows how NIH is unmatched in rare disease research. The Research is ongoing. Funding is needed to help beat this rare form of small intestinal cancer. It can sometimes leave the patient paralyzed and in much pain. Folks without adequate insurance need your help. Please consider donating to this worthy cause.
More information about this study and on Neuroendocrine Carcinoma can be found at gastrojournal.org
About Neuroendocrine Carcinoma from the Wikipedia website
Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.
Although there are many kinds of NETs, they are treated as a group of tissue because the cells of these neoplasms share common features, such as looking similar, having special secretory granules, and often producing biogenic amines and polypeptidehormones.